TipRanks
Go Ultimate55% OFF

Corteva (CTVA) Q2 2026 Earnings Report

CTVA Q2 2026 EPS Results

Actual EPS
$0.35
Consensus EPS
$0.34
Beat/Miss
Beat by +$0.01
One Year Ago EPS
$0.33

CTVA Q2 2026 Revenue Results

Actual Revenue
$6.38B
Expected Revenue
$6.60B
Beat/Miss
Missed by -$220.34M
YoY Revenue Growth
-1.19%

Earnings Announcement Details

Quarter
Q2 2026
Date
07/30/2026
Time
After Close
Conference Call
Thursday, July 30, 2026
CTVA Upcoming Earnings

Corteva's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

CTVA Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Jul 30, 2026|% Change Since:-11.33%|
Earnings Call Sentiment|Positive

The call delivered a broadly positive message: strong first-half execution drove revenue, margin and EBITDA gains; management raised full-year guidance and reported meaningful progress on the planned separation with dis-synergies largely mitigated. Notable challenges include crop protection pricing pressure (especially in Brazil), near-term cash flow impacts from one-time items, seasonal Q3 weakness and farmer margin/credit constraints in Latin America. Overall the company emphasized durable technology-led demand, productivity gains, and a healthy new product and licensing pipeline, while acknowledging localized and timing risks.

Company Guidance

Corteva raised full‑year 2026 guidance, now expecting operating EBITDA of $4.1–$4.3 billion and operating EPS of $3.60–$3.80 (midpoints imply ~9% EBITDA growth and ~11% EPS growth versus last year) with an operating EBITDA margin target of 22.5%–23.5%; that outlook is supported by a strong first half (net sales $11.3B, +4% YoY, organic +2%; Q2 net sales $6.4B), first‑half operating EBITDA $3.7B (+10%), operating EPS +14%, and margin expansion of nearly 200 basis points to ~32.8%. Management assumes seed organic growth of low‑single digits, crop protection volumes up high‑single digits (driven by new products) with pricing down low‑ to mid‑single digits, Brazil corn area ~flat, and typical seasonality (a Q3 operating EBITDA loss similar to 2024 with most second‑half earnings in Q4); year‑to‑date drivers include >$160M of cost/productivity savings, ~$90M improvement in net royalties, and an ~$85M favorable currency impact, and absent one‑time items they expect free cash flow conversion in line with prior midterm targets.

  • Raised Full-Year GuidanceOperating EBITDA guidance increased to $4.1B–$4.3B and operating EPS to $3.60–$3.80. At the midpoint this implies ~9% EBITDA growth and ~11% EPS growth versus prior year.
  • First Half Revenue and EBITDA GrowthFirst half net sales rose 4% to $11.3B (organic sales +2%). First half operating EBITDA increased 10% to $3.7B, driven by strong commercial execution across seed and crop protection.
  • Margin Expansion and EPSOperating margins expanded (nearly 200 bps of margin improvement referenced; margin reported at 32.8% in the first half). Operating EPS increased 14% in the first half.
  • Strong Seed Performance and Licensing MomentumOrganic seed sales improved across all regions (led by North America and EMEA). Net royalties improved by ~$90M and the licensing business is several years ahead of plan, with licensing contributing materially to pricing/mix.
  • Crop Protection New-Product MomentumNew crop protection products are a growing engine (~$2B of revenue expected this year from new products) with volumes up (high single-digit growth in new products) and pricing essentially flat in the first half for new introductions.
  • Productivity, Cost and Currency BenefitsCost and productivity improvements contributed >$160M to EBITDA; price & mix added ~ $100M; volume contributed ~ $40M; currency contributed ~ $85M — collectively driving ~ $350M year-over-year EBITDA improvement in H1.
  • Separation Progress and Lower-than-Expected Dis-synergiesSeparation (targeting Oct 1) on track with Form 10 filed, leadership and boards appointed, investor day planned. Run-rate dis-synergies largely offset; timing-related headwind this year reduced to ~ $25M (better than earlier estimates).
  • Long-Term R&D and Capital ReturnsSince 2019 the company invested nearly $9B in R&D, improved operating EBITDA by $1.7B and expanded margins by ~750 bps, while returning nearly $8B of cash to shareholders — supporting long-term value creation.

CTVA Earnings History

CTVA earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 11, 20262026 (Q3)0.02--0.04――
Jul 30, 20262026 (Q2)0.340.340.334.55% (+0.01)
May 05, 20262026 (Q1)0.180.230.1732.35% (+0.06)
Feb 03, 20262025 (Q4)0.030.030.05-31.25% (-0.01)
Nov 04, 20252025 (Q3)-0.08-0.04-0.0752.70% (+0.04)
Aug 06, 20252025 (Q2)0.280.330.2820.00% (+0.06)
May 07, 20252025 (Q1)0.130.170.1326.87% (+0.04)
Feb 05, 20252024 (Q4)0.050.050.02108.70% (+0.03)
Nov 06, 20242024 (Q3)-0.04-0.07-0.04-111.43% (-0.04)
Jul 31, 20242024 (Q2)0.260.280.2414.58% (+0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed
Show More